๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tumor antigens as related to pancreatic cancer

โœ Scribed by Dr. T. Ming Chu; E. Douglas Holyoke; Harold O. Douglass


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
576 KB
Volume
13
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cells of origin of pancreatic cancer: Ex
โœ Dale E. Bockman ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 821 KB

Human pancreatic adenocarcinoma is traditionally believed to be ductal in origin, primarily due to the presence of complexes of tubules interpreted as being derived from ductular proliferation. Although observations in various animal models of pancreatic tumors suggested that acinar cells wee underg

Serological immune response to cancer te
โœ Andreas Wadle; Boris Kubuschok; Jochen Imig; Beate Wuellner; Christine Wittig; C ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 380 KB

## Abstract Serological screening approaches have allowed for the identification of a large number of potentially relevant tumor antigens in cancer patients. Within this group, cancer testis antigens represent promising targets for cancer immunotherapy, since they are widely expressed in a variety

Selection of tumor antigens as targets f
โœ Shengle Zhang; Helen S. Zhang; Carlos Cordon-Cardo; Victor E. Reuter; Anil K. Si ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 409 KB

Blood group-related antigens have been attractive targets for immunotherapy of cancer since their initial identification as cancer-related antigens. However, available information on the relative expression of most of these antigens on human malignant and normal tissues has been insufficient for sel

Carcinoembryonic antigen and interferon
โœ Yoav Horn; Dalia Hacohen; Jacob L. Zeidman; Natalio Walach; Sally Sharf; Adi Hel ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval